Search Within

Troy Zachery Horvat

Formats
  1. Journal Article (8)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (11)
  2. Hematologic Malignancies, Division of (11)
  3. Clinical Pharmacy Specialists (7)
  4. Adult Leukemia (6)
  5. Biostatistics Service (6)
  6. Center for Hematologic Malignancies (6)

More Groups

People
  1. Amber King (7)
  2. Ryan Daley (7)
  3. Larry Buie (6)
  4. Martin Tallman (4)
  5. Michael Postow (4)
  6. Paul Chapman (4)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2017 (4)
  5. 2016 (3)
  6. 2015 (5)
Publications
  1. Blood (5)
  2. Annals of Pharmacotherapy (4)
  3. Journal of Clinical Oncology (4)
  4. Blood Advances (1)
  5. Leukemia Research (1)
Publishers
  1. American Society of Hematology (6)
  2. American Society of Clinical Oncology (4)
  3. Sage Publications (4)
  4. Elsevier Ltd (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The ABCs of immunotherapy for adult patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Horvat, T. Z.; Seddon, A. N.; Ogunniyi, A.; King, A. C.; Buie, L. W.; Daley, R. J.
    Annals of Pharmacotherapy (2018)

    Fulltext@MSK | Save
  • Biomarkers for predicting toxicity and response in adult acute lymphoblastic leukemia (ALL) patients treated with blinatumomab
    Meeting Abstract

    King, A. C.; Daley, R. J.; Horvat, T. Z.; Hsu, M.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Risk of hyponatremia and associated clinical characteristics in patients with acute lymphoblastic leukemia after CD19 targeted chimeric antigen receptor (CAR) T-cells
    Meeting Abstract

    Dixon, B. N.; Daley, R. J.; Horvat, T. Z.; Buie, L. W.; Hsu, M.; Latcha, S.; Brentjens, R. J.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax: A first-in-class oral BCL-2 inhibitor for the management of lymphoid malignancies
    Journal Article

    King, A. C.; Peterson, T. J.; Horvat, T. Z.; Rodriguez, M.; Tang, L. A.
    Annals of Pharmacotherapy (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of checkpoint blockade for treatment of advanced melanoma (mel) in patients (pts) age 80 and older (80+)
    Meeting Abstract

    Friedman, C. F.; Horvat, T. Z.; Minehart, J.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
    Journal Article

    Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; King, A. C.; Rampal, R. K.; Tallman, M. S.; Park, J. H.; Douer, D.
    Leukemia Research (2016)

    Fulltext@MSK | Save
  • Reply to A. Indini et al.
    Journal Article

    Horvat, T. Z.; Adel, N. G.; Dang, T. O.; Momtaz, P.; Postow, M. A.; Callahan, M. K.; Carvajal, R. D.; Dickson, M. A.; D'Angelo, S. P.; Woo, K. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save